- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Valneva SE ADR (VALN)
Valneva SE ADR stock price live, this page displays NASDAQ VALN stock exchange data. View the VALN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Valneva SE ADR real time stock price chart below.
What Is the Valneva SE ADR Stock Price Today?
The Valneva SE ADR stock price today is 7.13.
What Is the Stock Symbol for Valneva SE ADR?
The stock symbol for Valneva SE ADR is "VALN."
What Stock Exchange Does Valneva SE ADR Trade On?
Valneva SE ADR is listed and trades on the NASDAQ stock exchange.
Is Valneva SE ADR a Good Stock to Buy?
Determining whether Valneva SE ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VALN quote. (ISIN: US92025Y1038)
What Is the Valneva SE ADR Stock Price Today?
The Valneva SE ADR stock price today is 7.13.
What Is the Stock Symbol for Valneva SE ADR?
The stock symbol for Valneva SE ADR is "VALN."
What Stock Exchange Does Valneva SE ADR Trade On?
Valneva SE ADR is listed and trades on the NASDAQ stock exchange.
Is Valneva SE ADR a Good Stock to Buy?
Determining whether Valneva SE ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VALN quote. (ISIN: US92025Y1038)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.83
7.31
52 wk Range
4.75
12.25
Unusual Post-Market activity
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.837.31
52 wk Range
4.7512.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VALN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
12.25
Upside
+71.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Why is Valneva stock surging today?- Investing.com
- Why is Valneva stock surging today?
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 12.25
(+71.81% Upside)
Valneva SE ADR Earnings Call Summary for Q2/2026
- Valneva H1 2026 product sales fell 18.3% YoY to EUR 64M; operating loss widened to EUR 49.9M from EUR 16.8M amid restructuring charges.
- Company reaffirmed FY 2026 guidance of EUR 135-150M product sales and EUR 145-160M total revenue despite weaker first-half performance.
- Cash position strengthened to EUR 121.5M at June 30 from EUR 109.6M year-end; management targets self-sustainability starting 2027 if Lyme approved.
- Pfizer-partnered Lyme vaccine regulatory decisions expected within 12 months; CEO emphasized 'it's all about Lyme' for company's future value.
- H2 outlook improved by new DoD IXIARO contract, better gross margins, and 25-35% operating expense reduction from restructuring program.
Last Updated: 2026-08-13, 10:04 a/m
Read Full TranscriptEarnings
Latest Release
Aug 13, 2026
EPS / Forecast
-0.39 / -0.21
Revenue / Forecast
40.29M / 44.17M
Compare VALN to Peers and Sector
Metrics to compare | VALN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVALNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.6x | −3.5x | −0.4x | |
PEG Ratio | 0.03 | −0.05 | 0.00 | |
Price/Book | 7.0x | 0.9x | 2.6x | |
Price / LTM Sales | 4.0x | 19.4x | 3.1x | |
Upside (Analyst Target) | 82.3% | 148.3% | 48.3% | |
Fair Value Upside | Unlock | −6.3% | 6.2% | Unlock |
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. Valneva SE was founded in 1998 and is based in Saint-Herblain, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Valneva SE (VALN) Stock Price Today?
The Valneva SE stock price today is 7.13 USD.
What Stock Exchange Does Valneva SE Trade On?
Valneva SE is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Valneva SE?
The stock symbol for Valneva SE is "VALN."
What Is the Valneva SE Market Cap?
As of today, Valneva SE market cap is 658.26M USD.
What Is Valneva SE's Earnings Per Share (TTM)?
The Valneva SE EPS (TTM) is -0.88.
When Is the Next Valneva SE Earnings Date?
Valneva SE will release its next earnings report on Nov 12, 2026.
From a Technical Analysis Perspective, Is VALN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Valneva SE Stock Split?
Valneva SE has split 0 times.
How Many Employees Does Valneva SE Have?
Valneva SE has 674 employees.
What is the current trading status of Valneva SE (VALN)?
As of Aug 16, 2026, Valneva SE (VALN) is trading at a price of 7.13 USD, with a previous close of 5.65 USD. The stock has fluctuated within a day range of 6.83 USD to 7.31 USD, while its 52-week range spans from 4.75 USD to 12.25 USD.
What Is Valneva SE (VALN) Price Target According to Analysts?
The average 12-month price target for Valneva SE is 12.25 USD, with a high estimate of 18 USD and a low estimate of 5 USD. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +71.81% Upside potential.
What Is the VALN Premarket Price?
VALN's last pre-market stock price is 6.99 USD. The pre-market share volume is 1,930,000.00, and the stock has decreased by 1.34, or 23.72%.
What Is the VALN After Hours Price?
VALN's last after hours stock price is 6.77 USD, the stock has decreased by -0.36, or -5.09%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.